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An intrinsic enzymatic defect of PMN is responsible for the lack of
albuminuria in beige mice in the early heterologous phase of anti-GBM
nephritis. G. W. Feith, K.J.M. Assmann, M.J.J. T. Bogman, A.P.M.
van Gompel, J. Schalkwjk, R.A.P. Koene, Departments of Pathology,
Dermatology, and Nephrology, University of Nijmegen, The Nether-
lands. Intravenous injection of rabbit antibody against mouse GBM ir
the mouse causes a glomerulonephritis characterized by acute and
massive albuminuria. We have previously shown that the development
of early glomerular lesions and albuminuria were still present after
complement depletion, but failed to develop after PMN-depletion. The
acute albuminuria was also absent in C57B16J, bg/bg (beige) mice, in
which PMN are deficient for the leukocytic neutral proteinases elastase
and cathepsin G. To address the question whether an intrinsic defect in
the PMN or local factors in the beige kidney are responsible for the lack
of albuminuria in this strain, we conducted reciprocal bone marrow
transplantations (BMT) In beige and control (C57B16J, +1+) mice. BMT
was done one day after 10 Gy total body irradiation. Six weeks after
BMT, nephritis was induced, albuminuria was measured, and kidneys
were removed for (immuno-)histology. BM take was monitored by
measuring elastase activity in PMN extracts. After the injection of
antibody, albuminuria remained low (89 47 g/l8 hr; N = 6) in normal
beige mice. By contrast, in beige mice, reconstituted with BM from
control mice, acute albuminuria developed (3032 1408 tg/i8 hr; N =
8), a value only slightly lower than that in control C57BI6J, +1+ mice
(4411 3405 g/l8 hr; N = 6, P < 0.01). Albuminuria in control mice,
reconstituted with beige BM, was in the range of the normal beige mice
(112 55 pg/18 hr; N = 9). Reconstitution with syngeneic BM
demonstrated that BMT by itself did not influence the level of albumin-
uria. All mice showed similar morphological lesions with comparable
influx of PMN in the glomeruli two hours after antibody injection.
Elastase activities of PMN extracts in BMT groups were identical to
those in donor mice. We conclude that the absence of albuminuria ii
beige mice is caused by an intrinsic defect of leukocytic neutral
proteinase activity and not by local factors in the beige kidney.
Up-regulating activity of aspirin upon glomerular and arterial ectonu-
cleotidases as demonstrated in vitro and in vivo. P.K. Cheung, K.
Poeistra, J.J'. W. Bailer, and W. W. Bakker, Department of Pathology,
University of Groningen, The Netherlands, Previous cytochemical
studies have demonstrated that inhibition of prostacyclin (P012) pro-
duction by aspirin (ASA) was associated with increased glomerular
ADPas activity in the rat kidney, To further investigate this novel
action of aspirin, experiments were conducted to study the mechanism
of this phenomenon biochemically. Rats received a daily oral dose of
ASA (4 mg/kg body wt; group I, N = 6) or 0.5 ml saline (group II, N =
6). After 5 days kidneys were removed and glomeruli were isolated
according to standard sieving techniques. ADPase activity was as-
sessed in biochemical assays measuring phosphate release after incu-
bation with ADP according to standard procedures. Olomeruli of ASA
treated and normal rats were assayed in parallel experiments. Group III
(N = 6) consisted of glomeruli from non-treated rats incubated with 0.05
mr,i ASA in vitro. In addition, aorta vascular wall segments (7 mm2)
were incubated in vitro with either 0.05 to 1.0 msi ASA (group LV, N =
6), 0.05 to 1.0 mi minoxidil, which inhibits PGI2 synthetase (group V,
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N = 4), 0.05 to 1.0 m caffeine (group VI, N = 4) or 0.01 to 1.0 mri
norepinephrine (group VII, N = 4). Aorta segments incubated in saline
(group VIII, N = 6) served as controls. Results demonstrated a 68 3%
increase in glomerular ADPase activity in rats receiving ASA as
compared to saline treated rats (P < 0.05). This effect of ASA treatment
could be reproduced in vitro in isolated glomeruli (42 3% increase, P
< 0.05). Furthermore, the effect was not restricted to glomeruli since
aorta wall segments showed also a 49 4% increase in ADPase activity
following ASA incubation as compared to incubations in saline (P <
0.05). The mechanism of this ASA effect is unclear. However, since the
ADPase increasing effect of ASA could be mimicked by other PG!2
inhibiting drugs (minoxidil) as well as by cAMP increasing pharmacals
(caffeine, norepinephrine) in a dose dependent manner, it is speculated
that this effect is mediated by the adenylate cyclase system. The present
effect of ASA suggests that two major anti-aggregatory principles of the
vascular wall, that is, ADPase and PGI2, may be linked to each other.
Defective fibrinolysis in patients using cyclosporine after renal trans-
plantation; Beneficial effects of fish oil. M. Levi, f.M. Wilmink, and J. W.
ten Cafe, Academic Medical Centre, Amsterdam, The Netherlands.
Thromboembolic disease frequently occurs in cyclosporine treated
renal transplant patients (RTP). In this study the fibrinolytic activity
upon stimulation was studied in RTP on cyclosporine therapy using
RTP receiving azathioprine as controls. Furthermore, the effect of
co-treatment with fish oil (FO) was studied in a randomized, double
blind, crossover study. Twenty-nine RTP were studied: 20 used cyclos-
porine (eventually in combination with low dose prednisone) and 9 used
azathioprine and prednisone. Patients were randomized to receive
either FO 6 g/day or corn oil 6 g/day (CO). After 4 months the
alternative oil was given. To study the fibrinolytic response all patients
underwent a DDAVP test (0.4 pg/kg in 50 ml NaC1 over 15 minutes,
blood samples before and 5 minutes after DDAVP infusion) before the
start of the study period and after 4 and 8 months. Response of
plasminogen activators (PA), PA activity, tissue (t)-PA antigeen and
urinary (u)-PA antigen upon DDAVP and levels of PA inhibitors (PAl)
were determined. Before the start of the study period, in the cyclospo-
rine group 12 patients (60%) had no increase in PA activity upon
DDAVP. In 4 patients this absent response was due to high levels of
PAL, and in 8 patients no increase in PA antigen Ft-PA and u-PA (5k) or
t-PA alone (3 x)] was seen. One patient in the azathioprine group (11%)
had no response in PA activity upon DDAVP due to a high level of PAL.
After co-treatment with FO, 8 of the 13 patients with an initially absent
PA response upon DDAVP showed an improved PA activity response
upon DDAVP. All were patients with no release of PA antigen whereas
patients with high levels of PAl did not improve upon FO treatment.
Treatment with CO did not affect the PA activity response. In patients
who received FO in the first period and subsequently CO, an improved
PA response disappeared after cessation of FO therapy. In conclusion,
we observed a frequently occurring defective fibrinolytic response in
patients receiving cyclosporine due to high levels of PA! Or defective
PA antigen release. FO therapy appears to result in improved fibrin-
olytic response in patients with defective PA antigen release.
Reduced synthesis of proteoglycans in drug-induced renal cystic dis-
ease. L.P. van den Heuvel, T.J van de Velden, JR. Veerkamp, L.A.H.
Monnens, and J.H.M. Berden, Departments of Biochemistry, Pediat-
rics and Nephrology, University of Nmegen, Nzjmegen, The Nether-
lands. Since alterations in proteoglycans (PGs) may be involved in the
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pathogenesis of adult dominant polycystic kidney disease (ADPKD),
we analyzed PGs in an experimental rat model, diphenylthiazol (DPT)-
induced cystic disease, after labeling with [35Slsulfate in vivo. Glomer-
uli and tubules were isolated by a sieving procedure, basement mem-
branes were prepared with the detergent method, and proteoglycans
extracted with 4 M guanidine. PGs were purified by Q-Sepharose-HL
chromatography and identified with heparitinase and chondroitinase
ABC. Total sulfated PGs in tubular and TBM fractions of cystic kidneys
were reduced by 33 and 67%, respectively. GBM and glomerular
fractions did not display changes. The molecular mass and charge-
density of PGs synthesized by cystic glomeruli and tubules were similar
to those of controls, as revealed by gel permeation chromatography on
Sepharose CL-4B and chromatography on Q-Sepharose HL, respec-
tively. Also the glycosaminoglycan composition of glomeruli, GBM,
tubules and TBM from control and cystic kidneys was comparable, and
heparan sulfate was the predominant glycosaminoglycan present. Au-
toradiograms of tissue sections revealed reduced grain densities over
TBM in cystic kidneys compared to the homogenous distribution of
control kidneys. On indirect immunofluorescence a focally reduced
staining was observed with polyclonal anti-heparan sulfate proteogly-
can (HSPG) in the basement membrane of cysts, whereas the reactivity
with anti-collagen type IV and anti-laminin was unchanged. Normal
mRNA levels were found for collagen type IV and laminin in kidneys
from cystic rats, but HSPG mRNA levels were reduced by 50%. These
results indicate that the PGs have the same structure in renal cysts of
DPT rats as in normal tubules. The reduced synthesis of HSPG may
play a role in the pathogenesis of this disorder.
Activation of complement by IgA in vivo in a rat model. R.K. Stad*,
W.M.J.M, Bogers, M.E. van der Slays, L.A. van Es, and M.R. Daha,
Department of Nephrology, University Hospital Leiden, Leiden, The
Netherlands. In patients with primary IgA glomerulonephritis (IgAGN)
a combined deposition of IgA and C3 is observed in the mesangial area
of the glomerulus. Although activation of complement (C) by IgA is
controversial, a role for C in the tissue damage observed in IgAGN is
thus suggested. We have shown previously that rat monoclonal (MC)
IgA antibodies (Ab) are able to activate C in vitro. The degree of C
activation is dependent on the size of IgA. In the present study we
investigated the capacity of rat IgA to activate C in vivo in a rat model.
Rat monomeric (m-), dimeric (d-) and polymeric (p-) IgA mAb were
injected intravenously and assessed for deposition of C3 and C4 on IgA.
By ELISA it was shown that both d- and p-IgA bound C3. In contrast
no C3 fixation was observed with m-IgA. Polymeric IgA was more
efficient in binding C3 compared to d-IgA. However, in hemolytic
assays no consistent decrease of plasma complement levels was ob-
served. When rats were pretreated with cobra venom factor (CVF) to
deplete C3, no C3 deposition was found on m-, d- or p-IgA. Neither m-
nor d- or p-IgA was able to bind C4. In addition, triple immunofluores-
cent staining of liver tissue sections (which is the mean site of clearance
of IgA) revealed co-localization of C3 within p-IgA containing Kuppfer
cells (KC). No C3 was detected when rats were depleted of C using
CVF. Collectively, the experimental data suggest that d- and p-lgA are
able to activate C via the alternative pathway in vivo.
Two distinct binding mechanisms of anti-DNA monoclonal antibodies to
the glomerulus. R.M. Termaat, K.J.M. Assmann, H.B.P.M. Dijkman,
R.J.T. Smeenk, and J.H.M. Berden, Departments of Pathology and
Nephrology, University of Ndmegen and CLB Amsterdam, The Neth-
erlands. Anti-DNA antibodies are a diagnostic marker for the autoim-
mune disease, systemic lupus erythematosus (SLE), and it is generally
believed that these antibodies play a pivotal role in the pathogenesis of
SLE nephritis. Recently, we reported that anti-DNA Ab can bind to
heparan sulphate, a constituent of the glomerular basement membrane
(GBM), via DNA/histone complexes. We postulated that these histone/
DNA/anti-DNA complexes can bind via their histone part to the
glomerulus in vivo. To test this hypothesis we performed in the rat ex
vivo and in vivo renal perfusion studies using histones, DNA and a
monoclonal antibody (mAb) with high avidity for dsDNA. After ex vivo
perfusion of histones, DNA and subsequently anti-DNA mAb, with
immunoelectron microscopy (IEM) we found a strong binding on
endothelial cells in the glomerulus and to a lesser extent in the GBM.
When the anti-DNA mAb was injected intravenously one hour after in
vivo perfusion with histones and DNA, we observed a membranous-
like binding pattern with subepithelial granular immune deposits in the
IEM, accompanied by increased albumin excretion. After perfusion of
DNA followed by anti-DNA mAb, we also found binding in the
glomerulus that was, however, restricted to mesangial areas; binding to
endothelial cells or to the GBM was strinkingly absent. Also in this case
enhanced albumin excretion could be detected. No direct binding to the
glomerulus was observed after perfusion with anti-dsDNA mAb alone.
It is concluded that anti-DNA mAb can bind to the glomerulus via two
distinct mechanisms: 1) binding to mesangial areas via DNA alone; 2)
binding to endothelial cells and the GBM via histones and DNA.
Binding via both mechanisms can cause increased albumin excretion
and may be involved in the development of SLE nephritis.
Rat IgG enhances the production of IL-6 by rat renal mesangial cells.
M.E.A. van den Dobbeisteen, F.J. van der Woude, M.C. Krol, L.A.
van Es, M.R. Daha, Department of Nephrology, University Hospital
Leiden, Leiden, The Netherlands. The mesangium plays an important
role in processes of inflammation in the glomerulus. Previous studies
suggest that mesangial cells (MC) express Fc gamma receptors and that
they are activated by immune complexes resulting in excretion of
superoxide. It is also known that MC are able to produce IL-6 and IL-I.
These cytokines may function as autocrine growth factors. Since
immune complexes of various size may be involved in inflammation, we
have investigated the effect of soluble aggregates of IgG (AIgG) on MC.
After 24 hours of culture resting MC produced less than 1 to 5 U
IL-6/l04 cells. A more than 10-fold increase was observed in response
to treatment of MC with AIgG. The specificity of this enhancement was
studied by incubating the MC with Fc parts of rat IgG; the AIgG
enhanced 11-6 release was reduced by 70%. F(ab)2 fragments were not
able to inhibit this response. IL-6 production could be blocked with
cyclohexamide, which implies de novo synthesis of IL-6. Size fraction-
ation by HPLC indicated a size of 40 to 45 kD for rat IL-6. In agreement
with the functional data was the binding of fluorescent AIgG to the MC.
This binding could also be blocked with monomeric IgG. Additional
studies are in progress to determine whether MC are able to internalize
and degrade the immune aggregates which are bound to their surface.
Interleukin-6 and neopterin in renal transplant recipients. M.H.M.
Raasveld, E. Bloemena, S. Surachno, f.M. Wilmink, F.N.J. van
Diepen, P.Th.A. Schellekens, R.J.M. ten Berge, Clinical Immunology
Laboratory and Renal Transplant Unit, Academic Medical Centre,
Amsterdam, The Netherlands. To further elucidate the possible role of
interleukin-6 (IL-6) in the pathogenesis of renal allograft rejection and
its value in the differental diagnosis of renal transplant dysfunction, we
longitudinally studied serum and urinary IL-6 in 88 renal transplant
recipients during the first four months after transplantation. As a second
immunological marker we studied serum neopterin. During acute rejec-
tion episodes serum and urinary IL-6 levels were significantly increased
when compared to stable transplant function, and showed an increase at
least 2 days before plasma creatinine started to rise. During cytomeg-
alovirus disease (CMV) due to primary infection, serum neopterin
values showed a highly significant increase, by far exceding the also
significantly elevated neopterin levels during acute rejection episodes.
We conclude that: i) The rise in serum and urinary LL-6, preceding the
rise of plasma creatinine points to a possible involvement of IL-6 in the
pathogenesis of renal allograft rejection; ii) measuring of serum IL-6
provides a tool for the diagnosis of acute rejection episodes; and iii)
measuring of serum neopterin is highly sensitive for the differential
diagnosis of CMV disease and acute rejection episodes.
TNF alpha production by IL-i alpha stimulated proximal tubular
epithelial cells (PTEC) can be inhibited by pre-treatment of PTEC with
cyclosporine. A.B.A. Yard, ME. Paape, M.R. Daha, F.J. van der
Woude, L.A. van Es, Department of Nephrology, University Hospital
Leiden, Leiden, The Netherlands. In previous reports, we have shown
that human proximal tubular epithelial cells (PTEC) may function as a
target for graft infiltrating cells (GIC) during allograft rejection. We
recently found that IL-Ia stimulated PTEC can produce TNFa, a
cytokine known to have immune modulatory capacity. TNFa produc-
tion was measured using a standard TNFa bioassay with the TNFa
sensitive L929 mouse fibroblast cell line. A TNFa standard with well
known concentrations of this cytokine was included in each experiment
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to quantify the amounts of TNFa produced. Time response experi-
ments revealed that PTEC already showed significant production of
TNFa within two hours, after IL-la (I ng/ml) stimulation, reaching a
plateau at 48 hours. Blocking experiments showed that the TNFa
production could be completely inhibited by anti-IL-la MoAb. Further-
more, we showed that pretreatment of PTEC with the immunosuppres-
sive drug cyclosporine A for 72 hours completely blocked the TNFa
production by IL-la stimulated PTEC. Currently experiments are
undertaken to see if TNFa production is the result of de novo synthesis
or release from pre-existing pools. In addition, we are investigating if
PTEC also express the membrane bound form of TNFa and if this can
be up-regulated or induced by IL-la. From the data we conclude that
PTEC produce TNFa upon stimulation by IL-I a. This may have
implications for the immune response during allograft rejection, since it
is known that TNFa promotes renal injury and can activate T cells.
Cyclosporin A inhibits TNFa production by PTEC in vivo.
Anti-inflammatory potential of glomerular nucleotidases as demon-
strated in vitro. E.R. Heynen, K. Poelstra, J.F. W. Bailer, and W. W.
Bakker, Department of Pathology, University of Groningen, Gronin-
gen, The Netherlands. Recently, extracellular ATP and ADP have
received attention as important mediators in inflammatory reactions. It
has been shown that nucleotides released by platelets are able to prime
neutrophils, facilitating tissue damaging activity. These observations
suggest an anti-inflammatory role for glomerular ATP/ADPase activity
present in the rat kidney. To test this hypothesis we studied effects of
ATP and ADP as well as the end products of enzymatic degradation of
these nucleotides, that is, AMP and adenosine (ADO) upon O2
production by neutrophils in vitro. These cells were elicited intraperi-
toneally in Lewis rats according to standard methods. After 16 hours
peritoneal exsudate cells (PEC) were harvested. Aliquots of PEC
suspension (1.4 X lO cells/mi) were incubated with 10 sM ATP, ADP
or the non-degradable analogs ATPyS and ADP/3S. Additional samples
were incubated with supernatants of activated platelets, 10 /.LM AMP or
10 /LM 2-chioro-ADO (an analog of ADO). After 30 minutes (37°C) O2
production was assayed according to standard methods of either
serum-treated zymosan (STZ) stimulated or unstimulated PEC. Results
showed increased 02 production by STZ stimulated PEC preincubated
with ATP or ADP (32.8 16.5% increase as compared to STZ treated
PEC preincubated in saline, P < 0.05). ATPyS and ADPI3S showed
similar effects (45.0 33.0% increase, P < 0.05) excluding metabolic
effects of nucleotides upon PEC. Also, platelet secretory products
potentiated 02 production by PEC (32.7 15.6% increase, P < 0.05).
The products of ATP or ADP degradation, AMP and ADO (to prevent
rapid metabolism 2-chloro-ADO was used) displayed opposite effects.
AMP induced priming of PEC (30.3 19.2% increase, P < 0.05),
whereas 2-chloro-ADO significantly reduced 02 production by stimu-
lated PEC (30.6 11.9% reduction, P < 0.05). These results suggest an
anti-inflammatory role for glomerular ATP/ADPase by degradation of
ATP and ADP to ADO.
Detection of increased interstitial macrophages in acute rejection in
routinely processed renal allograft biopsies, using the monoclonal anti-
body KPI. Ph,M,M. Dooper, M.J.J.T. Bogman, A.J. Hoitsma, K.J.M.
Assmann, R.A.P. Koene, Departments of Pathology and Medicine,
Division of Nephrology, University Hospital N:jmegen, Nijmegen, The
Netherlands. Acute interstitial rejection (AIR) of renal allografts is
accompanied by a characteristic peritubular increase of macrophages
(mØ), which can be identified by staining with the CDI4 monoclonal
antibody (MoAb) WTI4. Since WTI4 is only applicable on cryostat
sections, we tested whether the interstitial increase of mØ can also be
demonstrated in routinely processed biopsies by use of the newly
developed CD68 anti-mØ MoAb KPI (Dakopatts), that is applicable on
paraffin sections. Allograft biopsies of 16 patients with clinical and
histological AIR and of 11 control cases with various histological
diagnoses other than AIR, were selected retrospectively from clinical
and pathological files. Three jm sections of Bouin's fixed, paraffin-
embedded renal biopsies were deparaffinized and stained with KP1 in
an avidin-biotin technique. KP1 positive cells were counted in 10
representative cortical high power fields (400 x). Of the 16 biopsies with
AIR two were completely negative for KPI. In the remaining 14 cases
of AIR the number of KP1 positive cells was 1184 410 per mm2 (mean
SD) and in the control biopsies 112 126 per mm2 (P < 0.001,
Wilcoxon rank sum test). In general, strong positivity for KPI was seen
in macrophages, whereas, especially in the AIR cases, a weaker
positivity was seen in peritubular monocytoid cells, with a distribution
similar to that found with WT14 in frozen sections. In retrospect, the
two negative cases of AIR proved to have been fixed in Bouin's fluid for
more than 40 hours (over the weekend), instead of the normal fixation
time of I to 4 hours. We conclude that with MoAb KPI an increase of
interstitial monocytes/macrophages, characteristic for AIR, can be
demonstrated in paraffin-embedded renal biopsies. Even fixation in
Bouin's fluid, with its low pH of 1.8, does not abolish binding of KP1,
provided that fixation times are kept within the recommended limits.
Rat mesangial cells (MCs) in culture decrease production of fibronectin
(FN) with increasing cell density. A. Wolthuis, A. Boes, and J. Grond,
Department of Pathology, University of Groningen, Groningen, The
Netherlands. MC proliferation and matrix expansion are key events in
glomerulosclerosis. Matrix formation may be affected by humoral
factors from the circulation or secreted locally by intrinsic glomerular
cells, infiltrating macrophages and platelets, or by increased cell-cell
contact secondary to hypercellularity. In the present study we exam-
ined the relationship between production of the adhesive matrix glyco-
protein FN and cell density of cultured MCs exposed to various
vasoactive agents. Rat MCs (passage # 7-10) were incubated in 24-well
plates for 3 days in medium with 0.5% fetal calf serum (FCS, no MC
growth), 0.5% FCS plus arginine vasopressin (AVP, 10—6 M, MC
growth 40% of that of 10% FCS), serotonin (5-HT, l0 M, MC growth
40%). and angiotensin II (Ang II, lO6 M, no MC growth), resulting in
cell numbers ranging from 20 to 250 x l0 eells/2 cm2. FN secreted into
the culture medium (SeFN) and intra/pericellular FN (cell-associated
FN, CaFN) were measured quantitatively using a sensitive sandwich
ELISA assay (pg FN/cell/3 days). CaFN was assayed after lysis of cells
and matrix. In all incubations (10 to II wells per experiment), negative
non-linear relationships were found between MC numbers (independent
variable, x) and SeFN as well as CaFN (dependent variables, y).
Logarithmic transformation normalized the distributions of x and y
variables and resulted in inverse linear relationships (log y = log a +
b . log x). The results of correlation and linear regression analyses are
given below:
r log a b sE(log a) sE(b) sE(log E)
SeFN
0.5% 4.3540 —0.5486° 0.2306 0.0456 0.0066
AVP 5.0123 0.1216 0.0245 0.0026
5-HT —0.9865° 4.7151 0.1841 0.0366 0.0054
Ang II —0.9909° 4.4486 0.1266 0.0257 0.0057
CaFN
0.5% —0.9944° 4.1387 0.1197 0.0241 0.0082
AVP —0.9676° 2.9890 —0.4586°' 0.1892 0.0348 0.0114
5-HT 3.8511 0.2960 0.0596 0.0111
Ang II —0.9618° 3.6820 0.2764 0.0563 0.0199
SE, standard error; E, residual.
P < .001 vs. 0; b P < .05, P < .001 vs. 0.5% FCS
In conclusion, MCs decreased FN production with increasing cell
density, independent of growth activity. This down-regulation may be
mediated in an autocrine feedback by FN accumulated in pericellular
matrix which had formed at higher cell densities. AVP may modulate
MC-matrix adhesion since this agent increased SeFN and decreased the
amount of CaFN.
Detection of amyloid AA in rectal biopsies with a new monoclonal
anti-human SAA antibody (REU.86.2). B.P.C. Hazenberg, J. Grond, D.
van den Top, J. Bjzet, P.C. Limburg, and M.H. van Ryswijk, Depart-
ments of Medicine and Pathology, State University Hospital, Gronin-
gen, The Netherlands. In 80% of the patients suspected to have
systemic amyloidosis with renal involvement a rectal biopsy confirms
the diagnosis. The present study addresses the reliability of a monoclo-
nal anti-human SAA antibody (Reu.86.2) to detect amyloid AA in
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formaline-fixed paraffin-embedded rectal biopsies. A total of 34 rectal
biopsies obtained from amyloidotic patients were found to be positive
for amyloid in the Congo red (CR) stain. KMnO4 pretreatment elimi-
nated CR staining in 30 specimens (AA-amyloid) whereas in 4 biopsies
CR staining was resistent to KMnO4 (non-AA). In our laboratory a
murine monoclonal antibody (Reu,86.2) was raised against apo-SAA
coupled to Helix Pomatia Haemocyanin. Paraffin-embedded sections
were incubated with Reu.86.2 (culture supernatant diluted 1: 100 in
PBSI1% BSA, 60 mm) as the first layer and peroxidase-conjugated
rabbit anti-mouse IgG as the second (15 mm). All 30 KMnO4-sensitive
specimens showed moderate or strong immunostaining with Reu.86.2;
in these biopsies the intensity of CR staining was moderate or strong in
18 and weak in 12 (Table). Twenty CR-negative controls and all 4
KMnO4-resistent biopsies were negative.
Table. Congo red versus Reu.86.2 in 54 rectal biopsies
Reu.86.2
Congo red
Total0 + +-,- +++
0
+
++
+++
Total
2o
—
—
—
20
—
5
7
12
1b
—
3
6
10
3b
—
—
9
12
24
—
8
22
54
0 = negative; + = weak; + + = moderate; + + + = strong staininga
negative controls; b KMnO4-resistent specimens
In conclusion, immunohistochemistry with monoclonal anti-SAA anti-
body Reu.86.2 is an easy and highly reliable method to detect amyloid
AA in rectal biopsies.
Aldose reductase inhibition normalizes the response to endogenous
angiotensin II in microalbuminuric diabetics. P.F.M.J. Spooren, ROB.
Gans, F.A. v.d. Wee!, CAM. Mecking, J.H.B. de BruUn, and A.J.M.
Donker, Medical Spectrum Twente, Enschede, and Free University,
Amsterdam, The Netherlands. Aldose reductase inhibition decreases
the concentration of sorbitol in cells of diabetic patients. This sorbitol
decreasing effect improves the metabolic condition of cells and prevents
possible diabetic complications. In hyperfiltering diabetic rats aldose
reductase inhibition normalizes glomerular filtration rate (GFR). In the
animal model dietary inositol supplements cause the same effects as
aldose reductase inhibitors. During infusion of captopril, GFR rises in
normal rats but decreases in experimental diabetic rats. Dietary inositol
supplements normalize this response. We have investigated this phe-
nomenon in fourteen patients with diabetes mellitus type I (N = 7) and
LI, and microalbuminuria. In these patients we measured GFR and
effective renal plasma flow (ERPF) with the constant infusion method
(51Cr-EDTA and '251-hippuran) at baseline, at one hour intervals during
infusion of angiotensin IL in incremental doses of 1, 3 and 6 ng/kg body
wt/min, and after captopril 25 mg orally before (0 wk) and after (8 wk)
treatment with the aldose reductase inhibitor, toirestat (Alredase').
Results are presented as means SEM.
Baseline
Owk 8wk
6ng
Angiotensin II
Owk 8wk
25mg
Captopril
Owk 8wk
ERPF 531 492 375 373 551 559
ml/min 32 32 21 22 41 41
GFR 112 107 114 113 114 114
mi/mm
GFR did not change significantly during angiotensin II infusion, nor did
it change after captopril before and after treatment with Airedase. In
contrast, ERPF decreased from 531 to 492 mI/mm (P < 0.025) at
baseline, while the values of ERPF were the same during administration
of angiotensin II or captopril before and after treatment with the drug.
During the maximal dose of angiotensin II the percentage difference
with baseline ERPF was greater before than after treatment (29.3 vs.
24.2%, P < 0.05). After 8 weeks of alredase administration the
percentage difference with baseline ERPF increased during captopril
(3.8 vs. 13.8%, P < 0.005). Thus, the sensitivity for exogenous
angiotensin II diminished, but the sensitivity for captopril increased
during treatment with airedase. In conclusion, our results suggest a
more physiological sensitivity for endogenous angiotensin LI in diabetic
patients with microalbuminuria after treatment with an aldose reductase
inhibitor. Further research is required to investigate the cause of this
altered sensitivity.
Effect of changes in daily protein intake on renal function in CR!:
Differences in reaction according to disease entity. G.H. Schaap, H.J.G.
Bib, J. van der Meuben, P.L. Oe, A.J.M. Donker, Department of
Internal Medicine, Free University Hospital, Amsterdam, The Nether-
lands. The mechanism by which protein restriction may slow down the
progression of renal failure remains unclear, with the most obvious
effect in patients with chronic glomerulonephritis (GN) and much less in
other disease entities such as adult polycystic kidney disease (APKD),
tubulointerstitial nephritis (TIN) and nephrosclerosis (NS). Decline of
hyperfiltration has been implicated. We studied the effects of prolonged
protein intake variation (isocaloric diets with four weeks periods of low
protein intake (30 to 40 g protein daily, LP) and high protein intake (80
to 90 g protein daily, HP) on renal function in 51 patients with CR1
divided into subgroups according to the underlying renal disease (GN,
N = 17; APKD, N = 9; TIN, N = 12; NS, N = 13). GFR and ERPF
were measured at the end of each study period. GFR in all 51 patients
rose from LP = 39 (9 to 90) to HP = 46 (9 to 100) ml/min/l.73 m2
(median and ranges, P < 0.01), ERPF from LP = 158 (39 to 558) to LP
= 171(32 to 676) ml/min/l .73 m2 (P < 0.01), GFR rose significantly in
GN (15%, range —23 to 51%), APKD (5%, range —10 to 33%) and NS
(8%, range —8 to 25%). ERPF only rose significantly in GN (14%, range
—45 to 47%) and APKD (9%, range —9 to 25%). An inability to vary
ERPF with dietary changes would implicate a decreased or lost renal
vascular reactivity. It remains possible that beneficial effects of protein
restriction in chronic renal insufficiency can be expected only in those
patients where renal blood flow can vary with changing protein intake,
that is, in patients with GM, and to a lesser extent in patients with
APKD.
Effects of long-term administration of aspirin on glomerular hyperfil-
tration in Fawn-Hooded rats. M.H. de Keijzer and A.P. Provoost,
Department Pediatric Surgery, Erasmus University Rotterdam, The
Netherlands. Male rats of the Fawn-Hooded (FH) strain develop a
syndrome consisting of hypertension, proteinuria and focal and seg-
mental glomerulosclerosis, culminating in deteriorating renal function
and premature death. In these rats, the decline in glomerular filtration
rate (GFR) is preceded by a period of hyperfiltration. Previous studies
suggested a prominent role of eicosanoids in both the initial hyperfil-
tration and the subsequent decrease in GFR. Thus prostaglandin
synthesis inhibition might affect the development of renal failure in FH
rats. We administered the cyclooxygenase inhibitor aspirin (ASA) to
FH rats and control rats of the WAG strain. Groups (N = 14) of FH and
WAG rats received drinking water without (PLAC) or with ASA (I
mg/mi). Every 12 weeks GFR (51Cr-EDTA), filtration fraction (FF),
urinary protein (UV) and the urinary excretion of PgE2 TxB2 and
6-ketoPgF1,, were determined. Continuous ASA administration did not
influence the body weight in WAG and FH rats. The excretion of PgE2
and 6-ketoPgF1,, was reduced in ASA-WAG rats during the first 24
weeks, later returning to control values. Compared to PLAC-WAG
rats, GFR and U,V of ASA-WAG rats were higher from week 24
onwards (P < 0.05). At week 12 higher eicosanoid excretion rates were
measured in ASA-FH rats than in PLAC-FH rats. With follow-up the
excretion of 6-ketoPgF1, returned to the level of PLAC-FH rats. The
excretion of PgE2 declined, but remained higher (P < 0.05) than that of
PLAC-FH rats, while TxB2 excretion increased even further. Initially
the GFR and FF of ASA-FH rats were significantly higher than those of
PLAC-FH rats. From week 36 the GFR of ASA-FH rats declined, while
the U,,V markedly increased from week 24 onwards, We conclude that
in WAG rats ASA administration temporarily decreases eicosanoid
excretion. The GFR, FF and U,V are increased after ASA, without
adverse long-term effects. In FH rats, ASA further increases eicosanoid
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excretion, accelerating the progressive renal failure normally occurring
in FH rats.
Effect of two weeks of high dose prednisone (Pred) on renal function in
patients without kidney disease. B.A.C. van Acker, M.F. Prummel,
W.M. Wiersinga, and L. Arisz, Departments of Nephrology and
Endocrinology, Academic Medical Centre, Amsterdam, The Nether-
lands. In a previous study a 10% increase in plasma creatinine concen-
tration (Per) was observed during Pred treatment in Graves' ophthal-
mopathy (GO) patients, suggesting that renal function deteriorates
during Fred treatment. We, therefore, studied changes in renal function
in 14 euthyroid GO patients (mean age 51, range 21 to 69 years; 75%
females), before (t = 0) and after two weeks (t = 14) Pred treatment (60
mg/day; N = 7) or retrobulbar radiotherapy (Controls; N = 7). All had
normal GFR, corrected for sex/age and negative history/signs for renal
disease, GFR and ERPF were measured as standard clearances during
continuous infusion of inulin and PAH. Tubular secretion (TS) of
creatinine (Cr) was calculated as clearance (C) of Cr minus GFR.
Differences in percentual changes (%z) between the two groups were
analyzed using the Mann-Whitney U test.
Prednisone(N 7)
t=0 t=l4 %
GFR ml/min/1.73 m2 91 4 102 6 12.2
ERPF ml/min/I.73 m2 455 23 487 21 7.5
Ccr ml/min/1.73 m2 110 5
TS ml/min/J.73 n2 19 2
121 5
18 5
10.6
PCr pino/Il 69 5 76 4 11.0
Ur pinol/h 490 40 560 50 14.9
Controls(N=7)
Pt=0 t=l4 %
80 5 80 4 0.4 <0.05
352 30 377 20 8.7 NS
96±6 99±3 4.4 NS
16±1 19±2 NS
73 5 74 5 2.5 <0.01
430 40 430 30 1.8 0.06
Data are given as mean SEM.
We again observed an increase in PCr during Pred treatment which,
however, was not a result of an impaired renal function, on the
contrary, GFR increased and probably U. as well (P = 0.06). TSc. did
not change. The rise in Cr may be due to the catabolic effect of Pred.
In conclusion, both plasma creatinine concentration and GFR rise
during two weeks of high dose prednisone treatment.
Increased apolipoprotein gene expression in the analbuminemic rat and
in the rat with Heyinann nephritis. J.A. Jo/es, X. Sun, H. Jones Jr., A.
van Tol, and GA. Kaysen, Rena/Biochemistry Lab, VAMC, Martinez,
California, USA; Department of Nephrology, University Hospital,
Utrecht, and Department of Biochemistry I, Erasmus University,
Rotterdam, The Netherlands. The nephrotic syndrome (NS) is associ-
ated with proteinuria, reduced colloid osmotic pressure (COP) and
hyperiipidemia. Increased hepatic synthesis of apolipoproteins (apo) is
involved in the hyperlipidemia of the NS. Whether this is due to the low
COP or to loss of some plasma factor through the diseased glomeruli is
unknown. We therefore measured the plasma levels of apoiipoprotein
(apo) A-I, apo B and apo E as well as the steady state levels of their
mRNA's, and the relative transcription rate of each mRNA in the liver
of hypoproteinemic rats with proteinuria (Heymann nephritis, HN), and
without proteinuria (Nagase hereditary analbuminemic rats, NAR) and
normoproteinemic control rats (CON).
N
mRNA steady state level
relative to /3-actin
mRNA
mRNA transcription rate
relative to 28S RNA
apo apo
A-I apo B E apo A-I apo B apo E
HN
CON
NAR
CON
7
4
8
6
2.7 4.0 8.6
0.3 0.2 0.6
1.5 2.8 8.8
0.1 0.3 0,2
6.4 12.7 7.5
0.sa 0.8 0.3
3.8 11.2 7.3
1.0 0.3 0.4
1.8 0.4 0.80.l 0.06 0.08
1.1 0.4 0.8
0.1 0.10 0.04
0.4 1.4 0.1
0.03 0.3 0.05
0.2 1.4 0.1
0.01 0.3 0.04
a P < 0.05 vs. control
Plasma levels of apo A-I, apo B and apo E were all increased
several-fold in both HN and NAR. Steady state apo A-I mRNA and its
transcription rate were both increased in the liver of HN and NAR. Apo
B mRNA was increased only in HN. Neither apo E mRNA, nor the
transcription rates of apo B mRNA or apo E mRNA, were increased in
HN or NAR. In conclusion: (I) reduced plasma albumin or COP cause
an increase in plasma apo's A-I, B and E, probably by stimulating an
increase in their synthesis rates, and (2) mechanisms regulating in-
creased synthesis of these apolipoproteins are not the same, apo A-I
being transcriptionally controlled, while apo B and apo E are post-
transcriptionally regulated.
Glucose polymers as osmotic agent in CAPD fluids: A more favorable
effect on peritoneal macrophage (PMO) function than glucose-based
solutions. C. W.H. de FUter, P.L. Oe, H.A. Verbrugh, E.D.J. Peters,
J.v.d. Meulen, A.J.M. Donker, R.A.M. Gokal, Free University Hospi-
tal Amsterdam and State University Uirecht, The Netherlands, and
Manchester Royal Infirmary, Manchester, England, United Kingdom.
The currently available peritoneal dialysis fluids (PDF) contain high
concentrations of glucose to establish an osmotic gradient. However,
these hypertonic concentrations of glucose have been shown to exceed
the osmotic tolerance of the phagocytic cells of the peritoneal cavity.
Consequently, local host defenses may be compromised. Recently,
Mistry et al introduced glucose-polymers which could obtain ultrafil-
tration using a solution that is nearly iso-osmolar. Therefore, we studied
the effect of this solution on PMO function. In a randomized crossover
setting, 8 CCPD patients performed an exchange (dwell time 1.5 hr)
with glucose or glucose polymers containing PDF on day one. The next
day the patients who had used glucose were switched to glucose
polymers and vice versa. PMO were isolated from the effluents and
tested for their phagocytic capacity and chemiluminescence response.
Compared to glucose exposure, PMO exposed to glucose polymers
containing PDF in vivo were significantly better able to phagocytize
both S. epidermidis (42 7.9 vs. 67 8.8% uptake, P < 0.005) and E.
co/i (21 6.7 vs. 63 9.1% uptake, P < 0.005). In addition PMO, after
an intraperitoneal dwell of glucose polymers containing PDF, produced
a significantly higher chemiluminescence response to phorbol myristate
acetate (peak chemiluminescence S 1.4 vs. 45 10.5% of control
neutrophils, P < 0.02). Thus, compared to glucose-based solutions,
PDF containing glucose polymers were significantly better in support-
ing PMO function and may, therefore, better maintain peritoneal
resistance to microbial invasion.
Phagocytosis of S. aureus adherent to cultured mesothelial cell mono-
layers by leucocytes and mesothelial cells. M.A. Muijsken, H.C.J.M.
Heezius, J. Verhoef, and H.A. Verbrugh, EUkman-Winkler Laboratory
for Medical Microbiology, State University Utrecht Medical School,
Utrecht, and R. Bee/en, Electron Microscopy Department, VU Hospi-
ta/, Amsterdam. Peritonitis, caused by staphylococci, is a major
complication of peritoneal dialysis. Previously we showed that S.
aureus (SA) adhere well to cultured human mesothelial cells (MC). We
studied whether phagocytosis of radiolabeled MC-adherent SA by
human phagocytes takes place in absence of opsonins. Polymorphonu-
clear leucocytes (PMN) rapidly phagocytized MC-adherent SA, reach-
ing 59.0 6.3% uptake at 1 hour. Preopsonization of SA increased
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adherence to MC (18.3 2.5 to 32.7 5.3%, P < 0.05), but did not
improve uptake. Monocytes (MN) phagocytized (non)opsonized SA
from MC monolayers at rates comparable to PMN. In contrast,
phagocytosis by peritoneal macrophages (PMO) from PD patients was
only marginal (<20% uptake). Pretreatment with inhibitors of cellular
function and pronase reduced the phagocytic capacity of PMN. It was
also shown that part of the adhered SA were resistant to lysostaphin,
suggesting ingestion of staphylococci by MC. This question was studied
using flow cytometry and electronmicroscopy (EM). Fluorescein la-
beled SA associated with more than 85% of MC after 1 hour. Preop-
sonization of SA resulted in a twofold higher fluorescence. EM showed
SA localized inside the MC. Quenching of extracellular SA with trypan
blue markedly reduced MC-associated fluorescence. Pretreatment of
MC with cytochalasin B reduced MC-associated fluorescence signifi-
cantly. Overnight incubation of MC with associated SA showed no
significant killing of intracellular SA. Rifampicin significantly reduced
the viability of intracellular SA. We conclude that the surface of
mesothelial cells provides favorable conditions for elimination of staph-
ylococci in the absence of opsonins. The poor phagocytic ability of
PMO suggests that they contribute little to the antibacterial defense of
the peritoneal membrane in PD-patients. Furthermore, we showed that
MC can phagocytize SA, but subsequently are not able to kill the
bacteria. This may have consequences for the choice of antibiotic
treatment of PD-peritonitis.
Glomerular ADPase activity after endotoxin infusion during different
reproductive conditions in the rat. MM. Faas, C.A. Visscher, G.A.
Schuiling, W. W. Bakker, Department of Pathology, Obstetrics and
Gynaecology, University Hospital Groningen, Groningen, The Nether-
lands. Pregnant rats are highly sensitive to endotoxin infusion com-
pared to non-pregnant rats as reflected by intraglomerular formation of
fibrinoid thrombi. This may be related to the increased sensitivity of the
glomerular antithrombotic enzyme ADPase. A much lower endotoxin
dose (1:20,000) is sufficient to decrease glomerular ADPase activity
during pregnancy as compared to non-pregnant controls. Since the
cause of this enhanced sensitivity for endotoxin during pregnancy is
unknown, we studied glomerular ADPase impairment in various endo-
crine conditions by infusion of endotoxin (1 Lg/kg body wt) in saline or
saline alone in pregnant (day 5, N = 10), non-pregnant (cyclic, N = 10),
ovariectomized (N = 10) and pseudopregnant (non-pregnant with
activated corpus luteum, day 5, N = 10) Wistar rats to evaluate the role
of pregnancy hormones in this increased sensitivity. Three days after
infusion, specimens of the left kidneys were prepared for enzyme
histochemistry to evaluate ADPase activity (Cerium-based method).
ADPase activity was scored in 4 kidney sections per animal by
lightmicroscopical evaluation of reaction product using a semi-quanti-
tative scale. From each individual rat 50 glomeruli per kidney section
were scored and the mean relative ADPase activity of the glomeruli per
section was calculated and expressed as an index. Endotoxin infusion
significantly decreased ADPase activity in the kidneys of pregnant rats
from 0.83 0.06 to 0.36 0.23 (mean SEM; Duncan, P < 0.05), but
not in that of cyclic (from 0.82 0.07 to 0.85 0.04), pseudopregnant
(from 0.69 0.21 to 0.67 0.09), or ovariectomized (from 0.55 0.2
to 0.58 0.19) rats. Furthermore, a significant (Duncan, P < 0.05)
overall reduction in glomerular ADPase activity was seen in the kidneys
of ovariectomized rats, suggesting a possible role of ovarian hormones
in the control of the ADPase activity of the rat kidney. The present
results 1) confirm that the increased sensitivity of the ADPase activity
for endotoxin during pregnancy is a specific pregnancy-associated
phenomenon and 2) that hormones like progesteron and prolactin are
very unlikely to be involved in this enhanced sensitivity, since these
hormones are increased during both the pregnant as well as the
pseudopregnant condition.
Simultaneous pancreas and kidney transplantation: The Leiden expe-
rience. E.C.A.A. v. Oosterhout, P.J. vd. Akker, H.v. Bronswjjk, H.G.
Gooszen, H.H.P.J. Lemkes, F.J. vd. Woude, andJ.L. Terpstra, Leiden
University Hospital, Leiden, The Netherlands. In a retrospective study
we analyzed the results of simultaneous pancreas and kidney transplan-
tation (SPK) in our hospital. Data from 20 patients transplanted
between January 1987 and July 1990 were collected. The exocrine
pancreas was drained on the bladder through a duodenocystostomy.
The immunosuppressive management was triple-therapy with cyclos-
porine, azathioprine and prednisone. HLA-DR matching was not done.
Mean age was 36 year (range: 23 to 50); the M/F ratio was 14/6; IDDM
had existed for 21 years (range: 14 to 39). All patients had a creatinine
clearance below 30 mI/mm; 6 patients had not been dialyzed, while the
other 14 had been on dialysis for an average period of 12 months.
Patient survival was 100%; pancreas and kidney graft survival were
62% and 65%, respectively, both after 1 year (N = 11) and after 2 years(N = 5). Mean serum creatinine levels were 162 mol/liter (N = 11)and
177 mo1/liter (N = 5) after I and 2 years, respectively. All patients
were treated for at least one rejection episode. The serum creatinine
level and renal biopsy were used as the main parameters for detection
of rejection. We found an increased hospitalisation period and a
decreased graft survival in patients who had experienced 3 or 4
rejection episodes.
Number of
antirejection
treatments N
Hospitalization
period days
mean (range)
1 year graft survival
%
pancreas kidney
1—2 7 58 (27—82) 71 86
3—4 13 92 (43—187) 62 46
We conclude that graft and patient survival after SPK in IDDM are
similar to recent data in the literature. Further improvement can be
expected from matching for HLA-DR antigens.
Better renal function, lower mean arterial pressure (MAP) and less
rejection episodes in cyclosporin A (CsA)-treated renal transplant recip-
ients fed dietary fish oil (FO). J.J. Homan van der Heide, H.J.G. Bib,
A.J.M. Donker, f.M. Wilmink, A.M. Tegzess, Departments of Internal
Medicine, University Hospital Groningen, Free University Hospital
Amsterdam, and University Hospital Amsterdam, The Netherlands. In
a randomized placebo-controlled double-blind trial 26 renal transplant
recipients were selected to ingest FO (30% C20:5 fl-3 = EPA and 20%
C22:6 fl-3 = DHA; daily 6 g), while 26 ingested coconut oil (CO) (63%
C8:O and 36% ClO:O) during the first 6 postoperative months. The
FO-treated patients had significantly higher GFR (FO :47 vs. CO :43
mI/mm) and ERPF (FO:2l3 vs. CO:170 mI/mm), and lower MAP
(FO: 103 vs. CO:1l3 mm Hg) at six months after grafting. The FO-
treated patients were requiring significantly less antihypertensive
agents than the CO-treated patients; 38 versus 94% (P < 0.05). The
cumulative percentage of rejection episodes amounted to 60 in the
CO-treated group versus 19 in the FO-treated patients (P < 0.05), and
the patients requiring conversion due to poor renal function amounted
to 19% in the CO-treated group versus 0% in the FO-treated patients.
We conclude that daily administration of 6 g fish oil has a beneficial
effect on renal haemodynamics, MAP and the incidence of rejection
episodes in CsA-treated renal transplant recipients.
Hyperinsulinemia: An unlikely pathogenetic mechanism for blood
pressure elevation in non-insulin dependent diabetes mellitus (NIDDM).
R.O.B. Gans, H.J.G. Bib, R.J. Heine, A.J.M. Donker, Free University
Hospital, Amsterdam, The Netherlands. Hyperinsulinemia has been
ascribed a role in the pathogenesis of hypertension associated with
NIDDM. This implies that in NIDDM the cardiovascular and renal
effects of insulin should be preserved despite resistance to its glucose
lowering action. Also, differences with respect to the former actions
between hypertensive (H-) and normotensive (N-) NIDDM should
exist. After a 2 hour basal period (Bas), we assessed, using the
euglycemic clamp, the effect of two doses of insulin, 50 (Ins I) and 500
(Ins 11) mU/kg/mm during 2 hour periods, on fractional sodium excre-
tion (FENa), heart rate (PR), systolic (5) and diastolic (D) blood
pressure (BP) in 8 H-NIDDM and 8 N-NIDDM, matched for age, sex
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and body mass index. On separate days control studies (C) were carried
out. All results (mean sEM) regard the last half hour of each period:
Bas
N H
FENa % 1.3 0.2 1.9 0.3
CFENa 1.1 0.2 1.6 0.4
SBP mm Hg 125 3 163 8
CSBP 124±4 156±7
DBPmmHg 75±2 92±3
C-DBP 71±2 90±3
PR.min' 68±4 68±4
C-PR 70±3 69±5
Ins I Ins II
N H N H
0.9 0,1 1.2 0.3 0.8 0.1 1.0 0.3
1.3 0.2 1.5 0.3 1.5 0.3 1.8 0.3
123±3 155±7 124±5 160±9
122±4 158±8 127±4 167±7
70±2 88±4 68±3 85±3
69±2 91±2 72±3 94±2
66±5 67±4 72±5 69±3
65±3 66±4 65±3 66±3
The 50% decline in FeNa indicates that the sodium retaining action of
insulin in NIDDM is preserved. In contrast to healthy subjects, a
decline in blood pressure during insulin infusion was noted. For none of
the responses differences between N-NIDDM and H-NIDDM were
found. This makes a causal role of insulin in the pathogenesis of
hypertension in NIDDM unlikely.
Mutations In the COL4A5 gene in Alport syndrome. H. Smeets, C.
SchrOder, J. Melenhorst, M. Ne/en, H. Brunner, H. Ropers, L.
Monnens, B. van Oost, Department of Human Genetics and Pediatrics,
University Hospital, Nmegen, The Netherlands. Alport syndrome
(AS) is a hereditary disease in which progressive renal failure is often
accompanied by deafness and ocular malformations. Typical ultrastruc-
tural abnormalities of the glomerular basement membrane (GBM) point
to a defective structural protein. In the majority of pedigrees close
linkage has been shown for AS to RFLP-markers in the Xq22 region.
Recently, the group of Dr. Tryggvason (Oulu, Finland) reported the
cloning of a new basement membrane collagen gene (COL4A5), which
mapped in the same chromosomal area. As yet, 3 mutations have been
identified in this gene in AS patients. We have used a probe mixture of
3' cDNA clones (provided by Dr. Tryggvason), covering the 14 terminal
exons of the COL4A5 gene, to screen the DNAs of 13 unrelated patients
for major gene rearrangements. Only one patient showed a large
deletion of the 3' end of the gene, indicating that most mutations in the
COL4A5 gene in AS will be rather small in size. Therefore, we started
screening COL4A5 exons for point mutations, initially focusing on
those exons coding for the non-collagenous domain of COL4A5. In our
search for single-stranded-DNA conformation polymorphisms (SSCP),
we detected in one patient a mutation in exon 4, which we are
characterizing further at the moment. Eventually, we hope to find a
correlation between the nature of the mutations and the expression of
the clinical picture in Alport syndrome.
Serum and urinary SCD27 levels in renal transplant recipients. M.E.D.
Chamuleau, R.Q. Hintzen, S. Surachno, f.M. Wilmink, R.A.W. van
Lier, R.J.M. ten Berge, Renal Transplant Unit and Clinical Immunol-
ogy Laboratory of the Academic Medical Centre of Amsterdam and the
Central Laboratory of the Netherlands Red Cross Blood Transfusion
Service, University of Amsterdam, SolubJ CD27 is the 32 kD mem-
brane form of the CD27 molecule that appears to be shed from activated
T-lymphocytes and can be detected both in the supernatant of activated
T-lymphocytes and in biological fluids. We have studied the course of
both serum and urinary levels of sCD27 in renal transplant recipients
longitudinally followed during a 4 month period after transplantation
(Tx). Serum samples were taken three times a week during clinical
follow-up and once a week in the outpatients' department. On the same
time points a portion of urine was taken from 24 hours collections.
Seven patients had suffered from primary cytomegalovirus (CMV), and
in 7 other patients 8 acute rejection episode(s) had occurred. Because
sCD27 appeared to be eliminated mainly by the kidney, serum sCD27
values were corrected for renal dysfunction. The results show a marked
rise of both corrected serum levels of sCD27 and urinary levels of
sCD27 during primary CMV infection. In contrast, during acute rejec-
tion episodes sCD27 levels did not show an increase either in serum or
in urine. Thus, corrected serum levels of sCD27 may be used as a
differential diagnostic tool between an acute allograft rejection episode
and primary CMV infection. Moreover, the lack of enhancement of
sCD27 levels during allograft rejection may give insight in the nature of
the cell population activated in this immune response.
Human plasma contains erythrocyte sodium efflux and influx stimulat-
ing factors. T. Tepper, J.F. Jilderda, R.M. Huisman, G.K. van der
Hem, D. de Zeeuw, Division of Nephrology, State University Hospital,
Groningen, The Netherlands. Previously we demonstrated the presence
of dialysable, low molecular weight (MW < 1000 D), Na-efflux stimu-
lating factors (ESF) in human plasma of healthy volunteers. In the
present study we tried to purify and characterize the ESF. Na-efflux
rate constant (ERC) and influx rate constant (IRC) in erythrocytes were
assayed using 22Na-tracer techniques. The ESF were recovered after
dialysis of plasma against artificial medium (Hank's). The ESF could be
absorbed on Dowex at pH 2 and Amberlite at pH 11, demonstrating
their "Zwitterionic" character. The ESF were hydrophylic, and resis-
tant to acid hydrolysis, indicating their non-peptidic nature. Amino
acids (AA) were reported to stimulate Na-efflux. To test whether the
ESF were AA, we measured ERC in plasma, Hank's and in Hank's
containing a plasma profile of AA (PAA). Indeed, FAA abolished the
ERC difference between plasma and Hank's (plasma = 100%; Hank's =
91.8 2.7%; FAA = 100 2.5%; N = 10). These results suggest that
PAA are responsible for the efflux stimulating properties of the plasma
"factors". However, the ESF might be counteracted by PAA or other
influx stimulating plasma factors (SF). Therefore, we measured IRC in
plasma, Hank's and Hank's with FAA. We found significantly higher
IRC values in plasma (0.032 0.005 hr') as compared to Hank's (0.020
0.004 hr1; N = 6), but no effect of PAA. Thus, PAA could not
abolish the IRC difference between plasma and Hank's. Additionally,
we observed that influx stimulating activity was recovered after dialysis
of plasma against Hank's. Apparently, plasma contains dialysable 1SF
which are not amino acids. In conclusion, human plasma contains both
sodium efflux stimulating factors, indentified as amino acids, and influx
stimulating factors of hitherto unknown nature. The presence of both
factors in human plasma and their opposing effects on cell sodium
homeostasis, may explain the diverging results of Na transport mea-
surement, either carried out in plasma or artificial medium, in different
disease states such as hypertension.
